Pulmonary Hypertension
Pulmonary Hypertension defined as a pulmonary arterial pressure greater than 25 mm Hg at rest or greater than 30 mm Hg during exercise, is often characterized by a progressive and sustained increase in pulmonary vascular resistance that eventually may lead to right ventricular failure. It can be a life-threatening condition if untreated. Therapy for Pulmonary Hypertension is targeted at the underlying cause and its effects on the cardiovascular system.
Pulmonary Hypertension (PHT) is high blood pressure in the heart-to-lung system that delivers fresh blood to the heart while returning used blood back to the lungs. Pulmonary Hypertension can develop slowly, without early signs and symptoms. When symptoms do occur, they may be attributed to asthma or other lung or heart conditions. To diagnose Pulmonary Hypertension, the doctor may ask about the symptoms and risk factors, including other medical conditions and family history. Having a family member with Pulmonary Hypertension increases the risk of developing the disease Medical evaluation.
- Pulmonary hypertension definition and facts
- Signs and symptoms of pulmonary hypertension
- Classification of primary and secondary pulmonary hypertension
- Causes for pulmonary hypertension
- Diagnosis of pulmonary hypertension
- Treatment and Medications for pulmonary hypertension
Related Conference of Pulmonary Hypertension
5th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
17th International Conference on Chronic Obstructive Pulmonary Disease
14th International Conference on COPD Clinical Trials & Lung Care Advances
16th International Conference on Pulmonary & Respiratory Medicine
Pulmonary Hypertension Conference Speakers
Recommended Sessions
- Airway and Therapeutic Devices
- Asthma and Allergy
- Cardio Pulmonary Disorders
- Chest Physiotherapy
- Chronic Bronchitis
- Chronic Obstructive Pulmonary Disease
- Emphysema
- Lung Cancer: Screening, Diagnosis & Treatment
- Lung Transplantation
- Paediatric Pulmonology & Critical care
- Pneumonia
- Pulmonary diseases: Treatment, Diagnosis and therapies
- Pulmonary Hypertension
- Pulmonary Rehabilitation
- Respiratory and sleep Medicine
- Respiratory Tract Infections
- Thoracic Tumors
Related Journals
Are you interested in
- Advances in Mechanical Ventilation and Respiratory Support - Pulmonology-2026 (Spain)
- Advances in Tuberculosis Diagnosis, Treatment, and Prevention - Tuberculosis-2025 (France)
- Airway Management Techniques in Critical Care Settings - Pulmonology-2026 (Spain)
- Asthma - Pulmonary Meet 2025 (France)
- Asthma and COPD - COPD_2025 (Spain)
- Asthma Management: Guidelines and Personalized Therapy - Pulmonology-2026 (Spain)
- Chronic Bronchitis - Pulmonary Meet 2025 (France)
- Chronic Obstructive Pulmonary Disease - COPD_2025 (Spain)
- Chronic Obstructive Pulmonary Disease (COPD) Updates - Pulmonology-2026 (Spain)
- Co-Morbidities of COPD - COPD_2025 (Spain)
- Community-based Approaches to TB and Lung Health Awareness - Tuberculosis-2025 (France)
- COPD - Pulmonary Meet 2025 (France)
- COPD and Cardiovascular Diseases - COPD_2025 (Spain)
- COPD Complications - COPD_2025 (Spain)
- COPD Exacerbations - COPD_2025 (Spain)
- COPD Pathogenesis - COPD_2025 (Spain)
- COPD Therapeutics - COPD_2025 (Spain)
- COPD: Sign and Symptoms - COPD_2025 (Spain)
- Critical Care Strategies in Sepsis and Multi-Organ Failure - Pulmonology-2026 (Spain)
- Cystic Fibrosis - Pulmonary Meet 2025 (France)
- Depression and anxiety in COPD - COPD_2025 (Spain)
- Digital Health Technologies for Respiratory Disease Management - Tuberculosis-2025 (France)
- Drug Discovery of COPD - COPD_2025 (Spain)
- Early Diagnosis and Biomarkers in Respiratory Diseases - Tuberculosis-2025 (France)
- Emerging Respiratory Threats and Pandemic Preparedness - Tuberculosis-2025 (France)
- Emphysema - Pulmonary Meet 2025 (France)
- Epidemiology of COPD - COPD_2025 (Spain)
- Ethical Dilemmas and Decision-Making in ICU Settings - Pulmonology-2026 (Spain)
- Genetic risk factor of COPD - COPD_2025 (Spain)
- Genetics and Susceptibility to Tuberculosis and Lung Diseases - Tuberculosis-2025 (France)
- Global Efforts to Eliminate Tuberculosis by 2030 - Tuberculosis-2025 (France)
- Hospital-acquired Infections and Respiratory Care - Tuberculosis-2025 (France)
- Immunotherapy and Biologics in Respiratory Diseases - Pulmonology-2026 (Spain)
- Impact of Smoking and Environmental Factors on Lung Health - Tuberculosis-2025 (France)
- Infectious Respiratory Diseases - Pulmonary Meet 2025 (France)
- Innovations in Interventional Pulmonology - Pulmonology-2026 (Spain)
- Interstitial lung disease - Pulmonary Meet 2025 (France)
- Latent Tuberculosis: Diagnosis, Treatment, and Control - Tuberculosis-2025 (France)
- Lung cancer - COPD_2025 (Spain)
- Lung Cancer - Pulmonary Meet 2025 (France)
- Lung Cancer Screening, Diagnosis, and Interventions - Pulmonology-2026 (Spain)
- Lung Health: Emerging Trends and Challenges - Tuberculosis-2025 (France)
- Lung Infections: Tuberculosis, Pneumonia, and Beyond - Pulmonology-2026 (Spain)
- Lung problems - Pulmonary Meet 2025 (France)
- Lung transplantation - Pulmonary Meet 2025 (France)
- Management of Acute Respiratory Distress Syndrome (ARDS) - Pulmonology-2026 (Spain)
- Multidrug-Resistant Tuberculosis (MDR-TB) and Novel Therapies - Tuberculosis-2025 (France)
- Neonatal and Maternal Respiratory Health - Tuberculosis-2025 (France)
- Non-Invasive Ventilation in Acute and Chronic Care - Pulmonology-2026 (Spain)
- Novel Therapies and Drug Development for Tuberculosis - Tuberculosis-2025 (France)
- Pathophysiology of COPD - COPD_2025 (Spain)
- Pediatric Pulmonary, Critical care and Sleep - COPD_2025 (Spain)
- Pediatric Pulmonology and Critical Care Challenges - Pulmonology-2026 (Spain)
- Pediatric Tuberculosis and Respiratory Health - Tuberculosis-2025 (France)
- Pleural Diseases - Pulmonary Meet 2025 (France)
- Point-of-Care Ultrasound in Critical Care Medicine - Pulmonology-2026 (Spain)
- Post-COVID Pulmonary Complications and Long-Term Care - Pulmonology-2026 (Spain)
- Prevention and Control of Respiratory disease - Pulmonary Meet 2025 (France)
- Pulmonary diseases-treatment and therapies - COPD_2025 (Spain)
- Pulmonary Fibrosis and Interstitial Lung Disease - Pulmonology-2026 (Spain)
- Pulmonary Hypertension - COPD_2025 (Spain)
- Pulmonary Hypertension - Pulmonary Meet 2025 (France)
- Pulmonary Hypertension: Diagnosis and Emerging Therapies - Pulmonology-2026 (Spain)
- Pulmonary Rehabilitation - Pulmonary Meet 2025 (France)
- Pulmonary Rehabilitation and Holistic Care for Respiratory Diseases - Tuberculosis-2025 (France)
- Pulmonary Rehabilitation and Patient-Centered Recovery - Pulmonology-2026 (Spain)
- Pulmonary vascular disease - Pulmonary Meet 2025 (France)
- Pulmonology - Pulmonary Meet 2025 (France)
- Respiratory Disorders - Pulmonary Meet 2025 (France)
- Respiratory Infections and Global Public Health Concerns - Tuberculosis-2025 (France)
- Respiratory Infections and Global Public Health Concerns - Tuberculosis-2025 (France)
- Respiratory Tract Infections - Pulmonary Meet 2025 (France)
- Role of Artificial Intelligence in Tuberculosis Diagnosis - Tuberculosis-2025 (France)
- Role of Imaging in Pulmonary Diagnostics and ICU Care - Pulmonology-2026 (Spain)
- Self-Management and Prevention of COPD - COPD_2025 (Spain)
- Sleep-Disordered Breathing and CPAP Therapies - Pulmonology-2026 (Spain)
- Sleep-Related Respiratory Disorders - Pulmonary Meet 2025 (France)
- Tuberculosis - Pulmonary Meet 2025 (France)
- Tuberculosis and HIV Co-infection: Challenges and Treatment - Tuberculosis-2025 (France)
- Tuberculosis Prevention and Global Public Health Strategies - Tuberculosis-2025 (France)
- Types of COPD - COPD_2025 (Spain)